Ferrous sulphate 200mg oral tablet ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 227 | Osler disease | 1 |
227. Osler disease
Clinical trials : 54 / Drugs : 73 - (DrugBank : 21) / Drug target genes : 23 - Drug target pathways : 136
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01908543 (ClinicalTrials.gov) | July 2013 | 23/7/2013 | Iron Deficiency and Hereditary Haemorrhagic Telangiectasia | Iron Deficiency and Hereditary Haemorrhagic Telangiectasia | Hereditary Haemorrhagic Telangiectasia | Drug: Ferrous sulphate 200mg oral tablet | Imperial College London | NULL | Terminated | 18 Years | 80 Years | All | 3 | N/A | United Kingdom |